Ananth J
J Int Med Res. 1977;5 Suppl 5:38-41.
An uncontrolled clinical study was carried out to evaluate the therapeutic efficacy of clomipramine (Anafranil, Geigy Pharmacueticals) in a group of twenty obsessive-compulsive neurotic patients. Clomipramine proved to be extremely useful in alleviating obsessive-compulsive neurosis as well as phobia. This finding was not secondary to the improvement in anxiety or depression which occurred, as the degree of improvement in obsessive symptoms far exceeded the improvement in the other symptoms.
开展了一项非对照临床研究，以评估氯米帕明（安拿芬尼，嘉基制药公司）对一组20例强迫性神经症患者的治疗效果。结果证明，氯米帕明在缓解强迫性神经症和恐惧症方面极为有效。这一发现并非继发于同时出现的焦虑或抑郁症状的改善，因为强迫症状的改善程度远远超过了其他症状的改善程度。
